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1. ~troduct~n 
The hormone-sensitive adenylate cyclase of many 
eucaryotic ells is controlled by the presence of 
guanyl nucleotides (reviewed [1,2]). The catalytic 
subunit is highly active in the presence of a guanyl 
nucleotide triphosphate but is inactive or poorly 
active in the presence of GDP [3-51. Hormones act 
in altering the configuration of the system to facilitate 
the access of the activating nucleotide triphosphate 
14-71. The switch-off mechanism of adenylate 
cyclase activity consists of the hydrolysis of the 
guanyl nucleotide triphosphate by the GTPase 
present in the system and can be i~ibited by a cholera 
toxin pretreatment ]&-IO]. 
According to this mechanism, GDP should be an 
antagonist of GTP action on adenylate cyclase. How- 
ever GDP itself cannot be tested since it is rapidly 
phosphorylated by the ATP-regenerating system 
present in the adenylate cyclase assay medium. We 
decided to use GDP& a GDP analog which is only 
slowly phosphorylated by the regenerating system 
Ill]. The system tested was the adenylate cyclase 
present in semi-pulled rat pancreatic plasma mem- 
branes. This system consists of at least 4 functionary 
distinct components: the catalytic unit; hormone 
receptors; and two classes of guanyl nucleotide sites, 
the first one N1 allowing the transduction of the hor. 
mane-generated signal and the second one Nz con- 
Abbreviations: GDPg3, guanosine Y-0.(2.thiodiphosphate); 
Hepes, N-2-hydroxyethylpiperazine-N’-2-Mhanesulfonic acid; 
TES, N-tris(hydroxymethyl)methyl-2aminoethane sulfonic 
acid; CCK-8, C-terminal octapeptide of cholecystokinin- 
pancreozymin (CCK-PZ); VIP, vasoactive intestinal peptide 
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trolling the activity of the catalytic unit 1121. This 
system is activated by the synergetic action of GTP 
and of a peptide belonging to either the secretin or 
the cholecystokinin-pancreozymin (CCK-PZ) family 
of hormones. 
In both hormone-activated native pancreatic 
plasma membranes and in cholera toxin pretreated 
membranes GDP@ proved indeed to be an antagonist 
of GTP activation of adenylate cyclase. The apparent 
affinity of GDP&S and GTP for the native system was 
6-7.fold higher in the presence of CCK-8 than in the 
presence of secretin. This suggests hat: 
(i) The number of CCK-8 receptors in pancreatic 
plasma membranes was higher than the number 
of secretin receptors; or 
(ii) Guanyl nucleotide binding sites directly 
associated with CCK8 and secretin receptors 
were distinct. 
2. Materials and methods 
Guanosine 5~~~2.~iodiphosphate) wassynthesized 
by Dr Eckstein (Max-Planck Institut fiir Experi- 
mentelle Medizin, G~tt~gen). Synthetic C-terminal 
octapeptide of cholecysto~n~-p~creo~min (CCK-8) 
and natural porcine secretin were generous gifts from 
Dr Lucania (Squibb institute for Medical Research, 
Princeton, NJ) and Dr Mutt (Karolinska Institutet, 
Stockholm), respectively. [o-“P]ATP and cyclic 
[8-3H]AMP were obtained from the Radiochemical 
Centre (Amersham, Bucks). Cholera toxin was from 
SchwarzjMann (Orangeburg, NY), Guanosine 
5’~~-~-~ido)triphosp~te and GTP were provided by 
Boehringer (Man~eim). ATP, phospho(enol)pyruvate, 
pyruvate kinase, and cyclic AMP were purchased 
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from Sigma Chemical Co. (St Louis, MO). ATP was 
purified by 3 successive chromatographies [ 131. All 
other reagents were commercial preparations of
analytical grade. 
Rat pancreatic plasma membr~es were prepared 
as in [ 141 and stored in liquid nitrogen until use. 
The cholera toxin pretreatment of these mem- 
branes was that developed for turkey erythrocytes 
[9]. Briefly, cholera toxin was preactivated at37°C 
in 1.5 ml cytosol of packed human erythrocytes. 
After 1.5 min incubation, an equal volume of pan- 
creatic membranes suspended in 20 mM Hepes buffer 
(pH 7.4) containing 2mM NAD’, 4 mM ATP, 10 mM 
phospho(enol)pyruvate, and 16 U pyruvate kinaselml 
was added. Membr~e protection was insured by the 
presence of soybean trypsin inhibitor (final cont. 
0.05 mg/ml), a suspension of hepatic phospholipids 
(0.2 mg/ml) and by decreasing to 30°C. The final 
toxin cont. was 30 pg/ml. After 5 min at 3O’C the 
toxin treatment of plasma membranes was stopped 
by adding 5 ml of ice-cold washing buffer composed 
of 10 mM TES (pH 7.4), 30 mM NaCl, 0.1 mM 
dithioerythritol and 0.5 mM EDTA. After immediate 
centrifugation at 50 000 X g for 10 min at 2’C, the 
pellet was rinsed out, resuspended in 5 mi washing 
buffer and centrifuged again. This washing procedure 
was repeated 3times. Washed membranes were flnally 
homogenized ina 10 mM TES buffer (pH 7.4) con- 
taining 30 mM NaCI, 0.2 mM EDTA, 0.1 mM MgCls, 
0.1 mM dithioerythritol, 0.05 mgJm1 soybean trypsin 
inhibitor, and 0.2 mg/ml phospholipid suspension, to
obtain final membrane protein cont. 0.5-l .O mg/ml. 
Control membranes underwent the complete proce- 
dure without cholera toxin addition. 
The adenylate cyclase activity was measured at 
37*C in a medium containing 30 mM Tris-HCl, 
5 mM MgC12, 0.5 mM EGTA, 1 mM theophylline, 
1 mM cyclic AMP, 0.5 mM [~x-~“P]ATP (l-2 pCi/ 
test), and an ATP regenerating system made of 
10 mM phospho(enol)pyruvate nd pyruvate kinase 
(15 U/ml). The pH was adjusted to 7.4 at 25°C. The 
reaction was initiated by addition of membranes and 
was conducted in 60 ~1. The reaction was stopped 
after 7 min incubation by addition of 0.5 ml 0.1% 
sodium dodecylsulfate solution containing 1 mM 
ATP and 0.5 mM cyclic [8-3H]AMP (-20 000 cpm). 
The isolation of cyclic [“P] AMP formed during 
incubation was achieved by sequential chromatography 
on columns of Dowex 50 WX-8 and aluminium oxide 
[ 151, Membrane protein was determined by the 
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Lowry method [ 161 using bovine serum albumin as 
standard. 
3. Results 
Native pancreatic adenylate cyclase was strongly 
stimulated by the two gastrointestinal peptides CCK-8 
and secretin provided that GTP was present in the 
incubation medium (table 1, fig.2). GTP alone was a 
very weak activator of native pancreatic adenylate 
cyclase so that the direct interaction of GDP@ with 
GTP could not be tested. By contrast, a cholera toxin 
pretreatment allowed a selective and 14-fold increase 
in GTP efficacy (table 1) in that GTP alone, when 
used at optimal concentration [ 171, now allowed 69% 
of the maximal activity observed in the combined 
presence of GTP and 1 PM CCK-8, as compared to 
5% in untreated control membranes. Using these 
experimental conditions, the dose-response curves of 
GTP activation illustrated in fig.1 indicate that 
GDPpS was a competitive inhibitor of GTP. The app. 
Ka of GTP was 0.10 PM and the Ki of GDPflS was 
0.60 PM. In another membrane preparation the 
corresponding values were 0.15 and 0.30 I.~M (table 2). 
Having established the status of GDPBS as a com- 
petitive inhibitor of GDP on cholera toxin-treated 
membranes, we next studied the action of GDPf3S on 
hormone-stimulated native adenylate cyclase (fig.2). 
In the absence of added GTP, GDPflS inhibited the 
significant stimulation of pancreatic membranes by 
Table 1 
Effects of cholera toxin pretreatment of rat pancreatic 
plasma membranes on adenylate cyclase activity 
Additions Membrane pretreatment 
Control Cholera toxin 
- 
None 142 2 128 f 23 
30 &f GTP 37t 8 729 * 198 
0.3 pM CCK-8 + 30 /JIM GTP 813i202 1061k 109 
10 mM NaF 932 + 129 315 f 97 
Plasma membranes were pretreated in the cytosol of human 
erythrocytes and in the absence or in the presence of 30 fig 
cholera toxin/ml, as in section 2. The adenylate cyclase 
activity of washed membranes was assayed in the standard 
medium or in the presence of 10 mM NaF or 30 MM GTP 
(with or without 0.3 pM CCK-8). The data are expressed as 
pmol cyclic AMP formed. min-’ . mg protein-‘. Means f SEM 
of 4 different preparations 
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Fig.1. Competitive inhibition by GDPflS of GTP activation 
of adenylate cyclase activity in pancreatic plasma membranes 
pretreated with cholera toxin. Rat pancreatic plasma mem- 
branes were pretreated with cholera toxin (30 &test) as in 
section 2. These membranes were then incubated with 
increasing concentrations of GTP in the adenylate cyclase 
assay medium containing highly purified ATP, and in the 
absence (0) or presence of 1 PM GDPBS (0) or 10 9M 
GDP&S (A). Dose-response curves of adenylate cyclase 
activation in the left panel are presented as Lineweaver-Burk 
plots in the right panel. In the latter representation, all values 
were corrected for basal adenylate cyclase activity. Results 
are the means of duplicate determination. In this experiment, 
the K, of GTP was 0.1 @M and the Ki of GDPpS was 0.6 PM. 
In another experiment with a distinct batch of pancreatic 
plasma membranes the values of K, and Ki were, 0.15 PM 
and 0.3 PM, respectively. 
CCK-8 while slightly enhancing the secretin-depen- 
dent activation (fig.2, middle panel). In the presence 
of added GTP, increasing GDP/IS concentration caused 
a progressive inhibition of hormone + GTP activation. 
0.3pM GTP ADDED 
7m 
0 -6 -5 _A 
GDP/% CONC.(LogM) 
There were again differences between CCK-8 and 
secretin-dependent activation in that: 
(i) GDP@ inhibited CCK8 stimulation more com- 
pletely than secretin activation (fig.2, left panel); 
(ii) The 1se of GDP@ inhibition (2.2 f 2 pM; n = 3) 
for CCK8 t GTP stimulation was lower than that 
for secretin t GTP stimulation (8 k 2 PM) (fig.2, 
right panel). 
The latter phenomenon was further investigated 
by determining the response of CCK-8 and secretin- 
stimulated pancreatic adenylate cyclase to increasing 
concentrations of GTP in the presence of two GDPPS 
concentrations (fig.3). In the presence of both secretin 
and CCK8, the inhibition by GDPPS was competitive 
Table 2 
CCK-8, secretin, and cholera toxin pretreatment on the 
affinity of GTP and GDPpS for regulation of adenylate 
cyclase activity in rat pancreatic plasma membranes 
Membrane Hormone K, for GTP Kifor GDPflS 
pretreatment addition OcM) 01M) 
- 
Cholera toxin None 0.15 -0.10 0.3 - 0.6 
Native CCK-8 0.043 f 0.006 0.5 + 0.1 
Native Secretin 0.28 * 0.04 3.2 i 0.4 
The apparent affinity constants K, and Ki for GTP and 
GDP&S, respectively, were calculated for cholera toxin pre- 
treated membranes from the 2 expt in fig.1. The same 
constants in hormone-stimulated native membranes were 
calculated from data in fig.3 (mean f SEM of 4 different 
preparations) 
0.6 _ 
OuM GTP 
z 1.0 
2- 
Ok - 42 
0 -8 -7 -6 -5 _f. 
GDP/3S CONC.(Log M) 
: 
Ia 01 I1 I1 
-6 -5 4 
GDP/% CONC. (Log Ml 
Fig.2. Effects of GDPpS on 0X-8 and secretin-stimulated pancreatic adenylate cyclase activity. Native pancreatic plasma mem- 
branes were incubated in the adenylate cyclase medium without (A) or with 1 MM CCK-8 (0) or 1 I.~M secretin (o), and in the 
presence of increasing concentrations of GDPflS. The experiment was performed in the presence (left panel) or absence (middle 
panel) of exogenous GTP, at 0.3 MM. In the right panel, adenylate cyclase activity, in the presence of 0.3 MM GTP is expressed as 
fraction of control activity in the absence of GDP&S. All values are the mean of 3 expt. 
277 
Volume 109. number 2 FEBS LETTERS January 1980 
1 pM SECRETIN 
I I I * - 
0 _8 17 -6 -5 -4 0 -6 _? -6 -5 _4 
GTP CONC. ( Log M ) 
Fig.3. Effect of GDP@ on GTP activation of pancreatic 
adenylate cyclase activity in the presence of CCK-8 or secretin. 
Rat pancreatic plasma membranes were incubated in the 
presence of increasing concentrations of GTP, and with or 
without 1 PM CCK-8 (left panel) or 1 PM secretin (right 
panel), and without (0, o) or with 3 /AM GDP/% (A, A) or 
30 PM GDPpS (m, 0). Results are means f SEM of experi- 
ments performed in duplicate without GDP@ (n = 4) or with 
3 KM GDPBS (n = 4) or 30 PM GDP@ (n = 3). 
with regard to GTP activation. In the presence of 
CCK-8, the adenylate cyclase activity recorded in the 
absence of added GTP was considered as due to 
endogenous GTP-like material on the basis of the 
evidence in fig.2 (middle panel). The apparent affinity 
of GTP action, extrapolated from dose-effect curves 
as shown in fig.3 (left panel), was significantly 
greater in the presence of CCK-8 (lya 0.04 PM) than 
in the presence of secretin (Ka 0.28 MM). 
4. Discussion 
Guanyl nucleotides activate pancreatic adenylate 
cyclase in synergy with CCK-8 or secretin 1171. 
CCK-8 alone produces however a significant activa- 
tion (3040% of maximal) whereas ecretin alone is 
3-times less efficient [ 171. This is puzzling since a 
peptide hormone alone should not activate an 
adenylate cyclase system operating through a hor- 
mane-nucleotide ~terdependent mech~ism [2]. Two 
explanations are conceivable: 
(i) Component(s) in our adenylate cyclase assay 
medium, La. ATP or plasma membranes, con- 
tamed enough GTP-like material for CCK-8 but 
not for secretin activation; 
The indication that pancreatic adenylate cyclase 
possess two functionally distinct guanyl nucleotide 
sites, one Nr indispensable for hormone coupling 
and another one Na promoting adenylate cyclase 
activity [ 12 J, may provide a clue for such a dis- 
crepancy. Hepatic plasma membranes [I8 f also con- 
tain functionally distinct guanyl nucleotide sites 
involved, respectively, in the regulation of hormone 
binding (N, sites) and adenylate cyclase activity (N2 
sites). In these membranes, GDP prevents the 
occupancy of N2 by GTP and the resulting activa- 
tion of the catalytical subunit. In contrast, GDP and 
GTP promote the coupling of the glucagon-receptor 
complex to adenylate cyclase with similar efficacy 
at Nr sites [19]. In pigeon erythrocytes, only one 
guanyl nucleotide binding protein related to adenylate 
cyclase activity has been isolated [20,2 l] but it is 
possible that this single protein displays changeable 
characteristics when promoting distinct regulatory 
events or that it contains everal guanyl nucleotide 
binding sites. 
(ii) CCK-8 alone was capable to activate adenylate 
cyclase by a mechanism distinct from the hor- 
The present data showed that the requirement for 
mone-nucleotide pendent system. 
GTP of CCK-8 activation of pancreatic adenylate 
The utilization of highly purified ATP [ 131 as 
cyclase was 7-fold lower than for secretin activation. 
Considering that both hormones finally activate the 
substrate was only capable to reduce the activation 
by secretin alone or CCK-8 alone (tig.2, middle 
panel). The present observation that low concentra- 
tions of GDPflS inhibited the residual activation by 
CCK8 alone (fig.2, middle panel) was thus required 
to demonstrate he presence of residual GTP-like 
material in the assay medium. 
That CCK8 alone was more efficient than secretin 
alone on pancreatic adenylate cyclase implied also 
that the action of CCK8 was more sensitive to GTP. 
In this respect we made a wrong assumption i f 171 
when estimating the Ka of GTP after subtract~g the 
activity observed in the absence of added GTP from 
dose-response curves of hormone-stimulated pan- 
creatic adenylate cyclase. Similar values of K, for 
GTP were then obtained in the presence of CCK-8 or 
secretin. This method was incorrect since we now 
know that the ho~onedependent activity observed 
in the absence of added GTP was due in fact to the 
presence of endogenous GTP-like material and cannot, 
therefore, be subtracted. The present data, based on 
the use of GDP@& clearly demonstrate hat the app. 
Ka of GTP for adenylate cyclase regulation was in 
fact 7 times higher in the presence of CCK8 than in 
the presence of secretin (table 2). 
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same catalytic unit associated with the same guanyl 
nucleotide regulatory site Na 1121, the difference in 
GTP action may be due to those guanyl nucleotide 
sites N, linked to hormone receptors. If the activa- 
tion-deactivation process operating at Ns sites, at 
saturating hormone concentration, isindeed con- 
trolied by the affinity of function Ni regulatory sites 
for nucleotides, the present data could be explained 
by two mechanisms: 
(9 
(ii) 
The guanyl nucleotide regulatory protein Nr 
associated with CCK-receptors differs from that 
associated with secretin receptors; 
CCK receptors 1221 are in excess over secretin 
(VIP) receptors (Robberecht et al., u~pubii~ed 
results} and catalytic subunits. 
The occupancy of a given fraction of Ni by GTP 
would allow the formation of more (CCK&receptor)- 
N, -GTP than (secretin-receptor)-Nr -GTP complexes. 
Despite the identical intrinsic affinity of GTP for all 
nucleotide regulatory binding sites Nr, the apparent 
affinity of GTP for CCK8-dependent stimulation 
would then be higher than that for secretin stimula- 
tion and this might provide a biochemical role for 
‘spare’ CCK-8 receptors in vitro 1231. 
Aided by grant 20,403 from the Fonds de la 
Recherche Scientifique Medicale (Belgium) and 
grant RO-IAM- from the National Institutes of 
Health (USA). 
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